Why the study?
Does intravenous ibutilide improve the conversion rate in patients with sustained atrial fibrillation or flutter?
Population
266 patients with sustained atrial fibrillation or flutter, with an arrhythmia duration of 3 hours to 45 days
Comparison
Intravenous ibutilide, up to two 10-minute… vs Placebo
Design
RCT, randomized
Follow-up
acute (mean 27 minutes after infusion)
Authors
Loading...
Supports ibutilide for acute AF/flutter conversion; confirms high efficacy versus placebo in this RCT.
Does intravenous ibutilide improve the conversion rate in patients with sustained atrial fibrillation or flutter?
Repeated intravenous doses of ibutilide are highly effective for the rapid conversion of atrial flutter and fibrillation, though associated with an 8.3% risk of polymorphic ventricular tachycardia.
Stambler et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: